Non-melanoma skin cancer in general practice: Radiotherapy is an effective treatment option
- PMID: 32738859
- DOI: 10.31128/AJGP-10-19-5130
Non-melanoma skin cancer in general practice: Radiotherapy is an effective treatment option
Abstract
Background: Skin cancer is the most common malignancy that is managed in general practice, and non-melanoma skin cancer (NMSC) comprises the vast majority of presentations. Radiation therapy (RT) plays an important part in the management of NMSC and may be used as definitive treatment for low-risk cancers, as an adjuvant treatment for high-risk disease or alone for inoperable cases.
Objective: The aims of this article are to discuss: 1) types of RT; 2) role of RT, including its advantages and disadvantages; 3) side effects (toxicity) of RT; 4) outcomes from RT; 5) low- versus high-risk NMSCs and 6) some guidelines for general practitioners on when to refer patients for consideration of RT.
Discussion: The primary goal of treatment for NMSC is to cure the patient, and a secondary goal is to provide the best cosmetic and functional result with the minimum impact on quality of life. In deciding what modality of treatment to use, clinicians will need to take into account the site of the tumour, clinical stage, histological subtype and any high-risk features, patient comorbidities as well as patient preferences. RT provides a safe and effective alternative to surgery in select cases and is particularly useful for the elderly or where surgery might have a negative impact on function or cosmesis.
Similar articles
-
Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.J Laryngol Otol. 2016 May;130(S2):S125-S132. doi: 10.1017/S0022215116000554. J Laryngol Otol. 2016. PMID: 27841126 Free PMC article.
-
The role of radiotherapy in the management of non-melanoma skin cancer.Australas J Dermatol. 2019 Nov;60(4):265-272. doi: 10.1111/ajd.13025. Epub 2019 Mar 31. Australas J Dermatol. 2019. PMID: 30931531 Review.
-
Practical indications for the management of non-melanoma skin cancer patients.G Ital Dermatol Venereol. 2017 Jun;152(3):286-294. doi: 10.23736/S0392-0488.17.05588-2. Epub 2017 Feb 14. G Ital Dermatol Venereol. 2017. PMID: 28195452 Review.
-
Current Role of Radiotherapy in Non-melanoma Skin Cancer.Clin Oncol (R Coll Radiol). 2019 Nov;31(11):749-758. doi: 10.1016/j.clon.2019.08.004. Epub 2019 Aug 22. Clin Oncol (R Coll Radiol). 2019. PMID: 31447088
-
Non-Surgical Therapeutic Strategies for Non-Melanoma Skin Cancers.Curr Treat Options Oncol. 2023 Dec;24(12):1978-1993. doi: 10.1007/s11864-023-01154-4. Epub 2023 Dec 14. Curr Treat Options Oncol. 2023. PMID: 38095778 Review.
Cited by
-
Innovative Topical Patches for Non-Melanoma Skin Cancer: Current Challenges and Key Formulation Considerations.Pharmaceutics. 2023 Nov 3;15(11):2577. doi: 10.3390/pharmaceutics15112577. Pharmaceutics. 2023. PMID: 38004557 Free PMC article. Review.
-
Advanced non-melanoma skin cancer in elderly patients: When surgery says NO, interventional radiotherapy (brachytherapy) says YES.J Contemp Brachytherapy. 2023 Aug;15(4):235-244. doi: 10.5114/jcb.2023.130715. Epub 2023 Aug 24. J Contemp Brachytherapy. 2023. PMID: 37799126 Free PMC article.
-
Evaluation of the clinical outcomes and patient satisfaction related to the use of internal eye shields for electron external beam radiation therapy.J Med Radiat Sci. 2024 Dec;71(4):555-563. doi: 10.1002/jmrs.812. Epub 2024 Jul 15. J Med Radiat Sci. 2024. PMID: 39010693 Free PMC article.
-
Identification of Metastasis-Associated Genes in Cutaneous Squamous Cell Carcinoma Based on Bioinformatics Analysis and Experimental Validation.Adv Ther. 2022 Oct;39(10):4594-4612. doi: 10.1007/s12325-022-02276-1. Epub 2022 Aug 10. Adv Ther. 2022. PMID: 35947350
-
A qualitative descriptive study of a novel nurse-led skin cancer screening model in rural Australia.BMC Health Serv Res. 2022 Aug 10;22(1):1019. doi: 10.1186/s12913-022-08411-6. BMC Health Serv Res. 2022. PMID: 35948920 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical